Repeated low-dose intradermal allergen injection suppresses allergen-induced cutaneous late responses

Low-dose intradermal allergen, like conventional subcutaneous high-dose immmunotherapy, suppresses allergen-induced cutaneous late responses in a manner that is allergen specific, systemic, and associated with induction of IgG antibodies.